Best Radiation Oncologists for Prostate Cancer in Chennai, India

Prostate cancer is a malignancy originating in the cells of the prostate gland, ranging from slow-growing, low-risk forms that may require only careful monitoring, to aggressive cancers that can invade nearby structures or metastasize to other parts of the body.

Early prostate cancer often causes no symptoms at all; when symptoms do appear, they may include difficulty urinating, a weak or interrupted urine stream, frequent urination — especially at night — blood in the urine or semen, or discomfort in the pelvic area. Advanced disease can cause bone pain, unexplained weight loss, or fatigue. These symptoms overlap with many non-cancerous conditions, and their presence or absence alone is not sufficient to establish or rule out a diagnosis.

Diagnosis typically begins with a PSA (prostate-specific antigen) blood test and a digital rectal examination, followed by imaging studies such as multiparametric MRI if findings are concerning. A prostate biopsy — often guided by ultrasound or MRI fusion — is generally required to confirm the presence of cancer and to determine its Gleason grade (now reported as a Grade Group from 1 to 5), which reflects how aggressive the cancer cells appear under a microscope. Clinical staging, using the TNM system, alongside PSA levels and Grade Group, guides the overall risk classification and shapes the treatment pathway — all of which must be interpreted by a qualified specialist familiar with the individual patient's full clinical picture.

Treatment decisions depend on the cancer's risk classification, stage, grade, the patient's overall health, age, and personal priorities, and should always be made in consultation with a specialist. Low-risk, slow-growing cancers may be managed with active surveillance — a structured programme of regular PSA tests, examinations, and repeat biopsies — avoiding immediate intervention while monitoring for any progression. For cancers that warrant active treatment, options span surgical removal of the prostate (radical prostatectomy, increasingly performed with robotic assistance), radiation-based approaches including intensity-modulated radiation therapy (IMRT) and brachytherapy, hormone therapy (androgen deprivation therapy), and in advanced or metastatic disease, chemotherapy or targeted agents.

Non-surgical pathways play a significant and well-established role in prostate cancer management. Active surveillance is a recognised standard of care for appropriately selected low-risk cases, while radiation therapy (IMRT or brachytherapy), hormone therapy, and systemic treatments offer effective non-surgical alternatives for a wide range of risk groups and disease stages. The suitability of any non-surgical approach depends on individual risk stratification and must be assessed by a qualified clinician.

Robotic Prostatectomy may be considered when conservative or medical options have not achieved enough improvement, or when the severity of the condition warrants it. The decision depends on clinical assessment, expected benefits and individual risks.

Prostate cancer is typically evaluated and managed by a urologist, often working in conjunction with a radiation oncologist for radiation-based treatments and a medical oncologist for hormone therapy, chemotherapy, or advanced disease management. Many centres with high case volumes operate a multidisciplinary tumour board where specialists review each case collectively before recommending a treatment plan.

When choosing a provider, it is worth asking about the number of prostate cancer cases the surgeon or centre manages annually, their specific experience with the procedure being considered (such as robotic prostatectomy or IMRT), whether a formal multidisciplinary team reviews cases, and what follow-up protocols — including PSA monitoring after treatment — are in place.

Share a medical summary, investigation and imaging or biopsy reports where relevant, a current medication list, previous diagnoses and related treatment records. Provide clear copies with translation where needed.

Our care coordination team helps review initial medical information, connect you with suitable doctors and hospitals, explain next steps and indicative estimates, and organise a treatment plan before travel.